Koch et al. [105] have recently shown that LCEV biogenesis is strictly dependent on ATP Binding Cassette Subfamily A Member 3 (ABCA3) expression, and that genetic ablation and chemical interference with ABCA3 expression improve drug accumulation in the nucleus of B-cell lymphomas. Here, ABCA3 is linked to B-cell non-Hodgkin lymphoma.